Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Berisa Hasanbegović"'
Publikováno v:
Journal of Health Sciences (2023)
Introduction: Breast cancer (BC) is the most common malignancy in the female population globally. Obesity is associated with an increased risk of postmenopausal BC, BC recurrence, and mortality. Fat mass and obesity-associated (FTO) gene polymorphism
Externí odkaz:
https://doaj.org/article/d15504d5c89d4301a44d5c80f75c066b
Autor:
Timur Cerić, Emir Sokolović, Berisa Hasanbegović, Anes Pašić, Zdenka Gojković, Jelena Vladičić Mašić, Nikolina Dukić, Inga Marijanović, Alma Mekić Abazović, Ibrahim Šišić, Dijana Koprić, Mustafa Hammami, Senad Bajramović, Taib Delić, Semir Bešlija
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Malignancy is one of the major public health problems in Bosnia and Herzegovina. Along with breakthroughs in specific oncological therapy, improving the quality of life of cancer patients and management of therapy-induced side effects need to be reco
Externí odkaz:
https://doaj.org/article/9b0b15bddcc0473c898c2d63ccc6603b
Publikováno v:
Medicinski Glasnik, Vol 16, Iss 1, Pp 77-82 (2019)
Aim To compare the effect of neoadjuvant chemotherapy based on taxane and/or anthracycline to the extent of an objective response in female patients with unresectable breast cancer with evaluation of the toxic profile of applied chemotherapy. Method
Externí odkaz:
https://doaj.org/article/a5cdcc40a4604e6a982bebffd19aca2c
Autor:
Timur Ceric, Emir Sokolović, Anes Pašić, Emina Borovac-Gurda, Velda Smajlbegović, Berisa Hasanbegović, Emina Bičakčić Filipović, Elma Kapisazović, Selma Sokolović, Semir Bešlija
Publikováno v:
Bosnian journal of basic medical sciences. 22(5)
The SARS-CoV-2 pandemic has been the main public health issue since the end of 2019. The vaccination campaign in Bosnia and Herzegovina started in April 2021, with several vaccines available. Our study aimed to evaluate the acceptance, effects, and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd66f5223ca81276d65be6034457d770
https://pubmed.ncbi.nlm.nih.gov/35427467
https://pubmed.ncbi.nlm.nih.gov/35427467
Autor:
Sijana H Dzinic, Zaid Mahdi, M Margarida Bernardo, Semir Vranic, Haya Beydoun, Nadine Nahra, Amra Alijagic, Deanna Harajli, Aaron Pang, Dan M Saliganan, Abid M Rahman, Faruk Skenderi, Berisa Hasanbegovic, Gregory Dyson, Rafic Beydoun, Shijie Sheng
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215089 (2019)
AimBarrett's esophagus (BE) is a predisposing factor of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma (ECA/GEJ Aca). BE patients are stratified and subsequently monitored according to the risk of malignant progression by the comb
Externí odkaz:
https://doaj.org/article/3887ae3927584dfd8ece29b3c3dd53ca